[HTML][HTML] Risk of venous thromboembolism in patients with COVID‐19: a systematic review and meta‐analysis

S Nopp, F Moik, B Jilma, I Pabinger, C Ay - Research and practice in …, 2020 - Elsevier
Background Venous thromboembolism (VTE) is frequently observed in patients with
coronavirus disease 2019 (COVID‐19). However, reported VTE rates differ substantially …

Increased VWF and decreased ADAMTS-13 in COVID-19: creating a milieu for (micro) thrombosis

EJ Favaloro, BM Henry, G Lippi - Seminars in thrombosis and …, 2021 - thieme-connect.com
von Willebrand factor (VWF) is a large adhesive multimeric protein involved in hemostasis.
The larger the size (or number of VWF multimers), the greater the functionality of the protein …

Endotheliopathy in acute COVID-19 and long COVID

AG Vassiliou, CS Vrettou, C Keskinidou… - International Journal of …, 2023 - mdpi.com
The pulmonary endothelium is a highly regulated organ that performs a wide range of
functions under physiological and pathological conditions. Since endothelial dysfunction …

Biomarkers of endothelial dysfunction and outcomes in coronavirus disease 2019 (COVID-19) patients: A systematic review and meta-analysis

MJ Al-Farabi, RA Nugraha, BA Marsudi, Y Azmi - Microvascular research, 2021 - Elsevier
Background Several studies have reported that the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) can directly infect endothelial cells, and endothelial …

Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory

M Hardy, T Lecompte, J Douxfils, S Lessire… - Thrombosis journal, 2020 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is associated with extreme inflammatory
response, disordered hemostasis and high thrombotic risk. A high incidence of …

ADAMTS13 activity to von Willebrand factor antigen ratio predicts acute kidney injury in patients with COVID‐19: Evidence of SARS‐CoV‐2 induced secondary …

BM Henry, SW Benoit, MHS de Oliveira… - … journal of laboratory …, 2021 - Wiley Online Library
Introduction Severe COVID‐19 is often compounded by a prothrombotic state that is
associated with poor outcomes. In this investigation, we aimed to evaluate ADAMTS13 …

Molecular insights into the thrombotic and microvascular injury in placental endothelium of women with mild or severe COVID-19

A Flores-Pliego, J Miranda, S Vega-Torreblanca… - Cells, 2021 - mdpi.com
Clinical manifestations of coronavirus disease 2019 (COVID-19) in pregnant women are
diverse, and little is known of the impact of the disease on placental physiology. Severe …

SARS-CoV-2 mechanisms of cell tropism in various organs considering host factors

E Behboudi, SN Faraji, G Daryabor, SMA Hashemi… - Heliyon, 2024 - cell.com
A critical step in the drug design for SARS-CoV-2 is to discover its molecular targets. This
study comprehensively reviewed the molecular mechanisms of SARS-CoV-2, exploring host …

Association between thrombocytopenia and 180-day prognosis of COVID-19 patients in intensive care units: A two-center observational study

Y Zhu, J Zhang, Y Li, F Liu, Q Zhou, Z Peng - PloS one, 2021 - journals.plos.org
Background Thrombocytopenia has been proved to be associated with hospital mortality in
patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections …

[HTML][HTML] Imbalance of von Willebrand factor and ADAMTS13 axis is rather a biomarker of strong inflammation and endothelial damage than a cause of thrombotic …

BS Joly, M Darmon, C Dekimpe, T Dupont… - Journal of Thrombosis …, 2021 - Elsevier
Background Critically ill patients with coronavirus disease 2019 (COVID‐19) are prone to
develo** macrothrombosis and microthrombosis. COVID‐19 has been reported to be …